<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: In patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:mp ids='MP_0002959'>microalbuminuria</z:mp> is associated with an increase in predominantly cardiovascular mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Considerable interindividual variability in the rate of progression of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> exists </plain></SENT>
<SENT sid="2" pm="."><plain>The prognostic significance of rate of progression of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> with regard to cardiovascular and renal clinical end points is, however, unknown </plain></SENT>
<SENT sid="3" pm="."><plain>The purpose of this study was to determine the prognostic significance of rate of progression of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> for cardiovascular end points and renal function </plain></SENT>
<SENT sid="4" pm="."><plain>RESEARCH DESIGN AND METHODS: In a previous prospective cohort study, progression of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (expressed as mean yearly change in albumin-to-<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio) was assessed in 58 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>During a median follow-up of 7 years after progression of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> was determined, we registered <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality and <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> mortality as primary end points and <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> (fatal or nonfatal), <z:hpo ids='HP_0004950'>peripheral vascular disease</z:hpo>, <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, macroalbuminuria, and change in serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> as secondary end points </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Seven subjects died during the study; five of these subjects died of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Cox's regression analysis identified progression of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> as a significant predictor of <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality (hazard ratio 1.46 per point increase in albumin-to-<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio per year, P &lt; 0.001), <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> mortality (hazard ratio 2.32, P = 0.006), and macroalbuminuria (hazard ratio 1.79, P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Adjustment for multiple <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> did not affect these results </plain></SENT>
<SENT sid="9" pm="."><plain>Identical analyses for baseline level of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> instead of progression rate of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> did not show significant hazard ratios </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, progression of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> significantly predicted an increase in serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> (r = 0.29, P = 0.04) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: In patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp>, the rate of progression of albumin excretion seems to be a powerful independent predictor of mortality caused mainly by <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> </plain></SENT>
</text></document>